Price as of close on Oct 23, 2026 · Financials updated Oct 1, 2026
Basics
Sector
Healthcare
Industry
Health Information Services
Country
United States
Market cap
595.3M USD
Enterprise value
564.9M USD
Full-time employees
904
Overall health
Strength:growing faster than most peersgrowing faster than peers
Drawback:less profitable than most peersless profitable than peers
Drawback:its shares are priced higher than most peers relative to what it earnspriced higher than peers for its earnings
Drawback:higher risk than most peers: its share price swings more than most peers’ (beta 1.69 vs a peer median of 0.63), less short-term liquidity (current ratio 1.25 vs a peer median of 2.59) and more debt relative to equity (0.60× vs a peer median of 0.22×)higher risk: bigger price swings (beta 1.69 vs peers 0.63), less liquidity (current ratio 1.25 vs peers 2.59) and more debt vs equity (0.60× vs peers 0.22×)
Ranks #995 of 1,157 healthcare companies (bottom 15%)
Shareholders being diluted. Shares outstanding up 22% from December 2022 to August 2026.
Weave Communications had 22% more shares at August 2026 than at December 2022, mostly from issuing stock (for pay, acquisitions or fundraising). Each existing share now owns a smaller slice of the business.Weave Communications had 22% more shares at August 2026 than at December 2022, mostly from issuing stock. Each existing share now owns a smaller slice of the business.
Stock-based pay is a large cost. Stock pay was 13% of revenue in 2025.
Weave Communications paid employees $32M in stock in 2025, 13% of its $239M revenue. It doesn't use cash, so it flatters cash flow, but it is a real cost to shareholders through dilution.
Operating loss narrowing. Operating margin -13% in 2025, the smallest loss relative to revenue of the last 6 years.
Weave Communications still lost money on operations in 2025 (margin -13%), but that was its smallest operating loss relative to revenue in the 6 years of filings we have.
Valuation signals disagree. Cheaper than 50% of peers on free cash flow, but only 0% on earnings.
Relative to its free cash flow, Weave Communications looks cheaper than 50% of peers; relative to its earnings, cheaper than only 0%. The valuation score blends the two, so look at which measure fits this business best.
Sector-normalized EBITDA, earnings, and free cash flow yields.
Earnings yield-3.5%
SEC filings · 12 months to Jun 2026Negative (a loss or cash outflow), so it counts as zero whatever the share price30% base weight · Z-score -1.00Sector median: 0.0148 · MAD: 0.0148
EBITDA yield-1.7%
Yahoo Finance fallback · SEC enterprise value unavailable (debt or EBITDA not reported in standard form) · trailing 12 monthsNegative (a loss or cash outflow), so it counts as zero whatever the share price50% base weight · Z-score -1.00Sector median: 0.0401 · MAD: 0.0401
Free cash flow yield2.4%
SEC filings · 12 months to Jun 2026 · operating cash flow − capital spendingReported value20% base weight · Z-score 0.00Sector median: 0.0000 · MAD: 0.0000
Why it changed since the Oct 23, 2026 close: Safety percentile 16 → 17
Peer companies moved+1
Each step re-scores the company against its peers as they were on Oct 28, 2026; the parts add up to the change. Price effects on EBITDA yield are approximate.
Yahoo Finance fallback · no standard SEC debt tagReported value33% base weight · Z-score -1.88Sector median: 0.2215 · MAD: 0.2039
Valuation, growth and profitability scores: higher is better. Risk: 0 is lower, 2 is higher. Risk is a relative proxy, not a bankruptcy probability. Scores depend on available sector peers.
Questions investors ask about Weave Communications
Is Weave Communications getting weaker?
Its latest SEC filing (Aug 6, 2026) got stronger: operating margin rose 2.6 points to -8.3%. Its overall score is unchanged at 29/100 since Oct 28, 2026.
How is Weave Communications valued vs its peers?
Priced higher than most peers relative to what it earns. Valuation scores 8/100 against 1,393 healthcare peers.Earnings yield -3.5% vs a peer median of 1.5% (weaker than 100% of peers).Earnings yield -3.5% vs peers 1.5% (weaker than 100% of peers).
Is Weave Communications growing?
Yes, faster than most of its peers. Growth scores 70/100 against 1,393 healthcare peers.3-year revenue growth 18.4% vs a peer median of 5.8% (stronger than 79% of peers).3-year revenue growth 18.4% vs peers 5.8% (stronger than 79% of peers).
How profitable is Weave Communications?
Less profitable than most of its peers. Profitability scores 23/100 against 1,393 healthcare peers.Return on invested capital -45.5% vs a peer median of 4.7% (weaker than 87% of peers).Return on invested capital -45.5% vs peers 4.7% (weaker than 87% of peers).
How risky is Weave Communications?
Higher risk relative to 1,393 healthcare peers, judged on debt, liquidity and share-price swings.Beta 1.69 vs a peer median of 0.63 (weaker than 90% of peers).Beta 1.69 vs peers 0.63 (weaker than 90% of peers). A relative measure, not a bankruptcy probability.
Latest filing: what changed
Quarter ended Jun 30, 2026 · filed Aug 6, 2026 · compared with the quarter ended Mar 31, 2026
Got stronger
Operating margin rose 2.6 points to -8.3%
Previous quarter
Latest quarter
Change
Revenue (12 months)
248.7M USD
257.8M USD
+3.6%
Net income (12 months)
−25.0M USD
−20.5M USD
−17.8%
Operating margin
-11.0%
-8.3%
+2.6 pts
Free cash flow (12 months)
9.6M USD
14.3M USD
+49.1%
Cash
42.2M USD
47.6M USD
+12.8%
Shares outstanding
79.6M
80.0M
+0.5%
From the company’s own SEC filings, as filed. Twelve-month figures roll forward one quarter at a time.
Industry valuation context
Sector: Healthcare · 301 companies
Valuations in Healthcare are within their usual range since 2016.
52% of months since 2016 were valued lower than now.
19% of companies are in the most expensive fifth of their own price-to-sales history.
Over 24 months, company values +8% and earnings +24% (medians): earnings grew faster than prices.
Median price-to-sales is +63% vs the whole market, against a usual +119%.
2016Shaded: most expensive fifth of its range2026
Shown for Healthcare: too few Health Information Services companies have a long enough history of their own.
Earnings-based measures are left out for now because many companies in Healthcare are losing money.
Describes valuations since 2016; it does not predict prices. US companies worth $1B+, from SEC filings and month-end prices, as of Aug 2026. Today's companies and industry labels are used throughout. Measured on sales and free cash flow yields. How this works
Financials
Fiscal years from SEC annual filings · change vs the prior year
Key ratios
FY 2021
FY 2022
FY 2023
FY 2024
FY 2025
Change
Gross margin
57.4%
62.5%
68.1%
71.4%
72.1%
▲ 0.7 pts
Operating margin
-43.5%
-35.0%
-20.2%
-15.4%
-12.8%
▲ 2.6 pts
Net margin
-44.6%
-35.0%
-18.2%
-13.9%
-11.7%
▲ 2.1 pts
Return on assets (ROA)
-27.6%
-23.9%
-15.4%
-15.0%
-13.5%
▲ 1.5 pts
Return on equity (ROE)
-46.0%
-59.8%
-39.3%
-42.3%
-34.1%
▲ 8.3 pts
Free cash flow margin
-23.9%
-10.3%
5.0%
5.9%
6.3%
▲ 0.5 pts
Current ratio
2.84×
1.84×
1.78×
1.58×
1.24×
▼ 21%
Debt to equity
0.09×
0.12×
0.00×
—
—
—
Interest coverage
-42.56×
-34.49×
-17.87×
-20.63×
-18.01×
▲ 13%
WEAV price history
Price history is added with the daily price update and will appear after the next one.